DrugDashboards

Ropinirole

Ropinirole · ROPINIROLE HYDROCHLORIDE 4 mg/1 · Tablet, Extended Release · Oral · Elite Laboratories, Inc.

NDC 64850-0251-30 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Sep 2026Sep 2026$0.506
1 price point · per EASource: CMS NADAC

Estimated fill cost

#30 count
$15.18
#90 count
$45.54

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 3 active manufacturers+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for ropinirole (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA217862
TE code
AB
Approval date
Nov 10, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ropinirole (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackROPINIROLE HYDROCHLORIDE 12 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackROPINIROLE HYDROCHLORIDE 8 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackROPINIROLE HYDROCHLORIDE 6 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackROPINIROLE HYDROCHLORIDE 4 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackROPINIROLE HYDROCHLORIDE 2 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.ROPINIROLE HYDROCHLORIDE 8 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.ROPINIROLE HYDROCHLORIDE 12 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.ROPINIROLE HYDROCHLORIDE 2 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.ROPINIROLE HYDROCHLORIDE 4 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.ROPINIROLE HYDROCHLORIDE 6 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCROPINIROLE 2 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCROPINIROLE 4 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCROPINIROLE 8 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCROPINIROLE 12 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCROPINIROLE 6 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ropinirole — NDC 64850-0251-30," retrieved September 3, 2026, https://drugdashboards.com/drug/64850025130.

Free to cite with attribution — see how the data is put together.